T. Rowe Price Associates’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.8M Sell
544,444
-63,497
-10% -$6.1M 0.01% 775
2025
Q4
$56.5M Sell
607,941
-123,542
-17% -$13.5M 0.01% 780
2025
Q3
$91.1M Buy
731,483
+495,985
+211% +$63.1M 0.01% 641
2025
Q2
$31M Buy
235,498
+201,613
+595% +$22.8M ﹤0.01% 858
2025
Q1
$3.55M Buy
33,885
+2,123
+7% +$222K ﹤0.01% 1365
2024
Q4
$3.45M Sell
31,762
-122
-0.4% -$13.6K ﹤0.01% 1406
2024
Q3
$3.41M Sell
31,884
-100
-0.3% -$10.1K ﹤0.01% 1416
2024
Q2
$3.17M Buy
31,984
+1,686
+6% +$170K ﹤0.01% 1383
2024
Q1
$2.8M Buy
30,298
+1,765
+6% +$142K ﹤0.01% 1422
2023
Q4
$2.15M Buy
28,533
+1,072
+4% +$69.7K ﹤0.01% 1491
2023
Q3
$1.66M Buy
27,461
+1,189
+5% +$81.6K ﹤0.01% 1550
2023
Q2
$1.9M Sell
26,272
-267
-1% -$16.9K ﹤0.01% 1495
2023
Q1
$1.47M Buy
26,539
+2,192
+9% +$121K ﹤0.01% 1592
2022
Q4
$1.23M Buy
24,347
+1,097
+5% +$54.2K ﹤0.01% 1665
2022
Q3
$980K Sell
23,250
-2,855
-11% -$142K ﹤0.01% 1761
2022
Q2
$1.29M Buy
26,105
+2,814
+12% +$140K ﹤0.01% 1779
2022
Q1
$1.23M Buy
23,291
+2,325
+11% +$130K ﹤0.01% 1902
2021
Q4
$1.44M Sell
20,966
-5,986
-22% -$421K ﹤0.01% 1849
2021
Q3
$2.04M Sell
26,952
-770
-3% -$66K ﹤0.01% 1717
2021
Q2
$2.77M Sell
27,722
-47
-0.2% -$4.36K ﹤0.01% 1635
2021
Q1
$2.46M Sell
27,769
-1,136
-4% -$112K ﹤0.01% 1641
2020
Q4
$2.77M Buy
28,905
+1,597
+6% +$123K ﹤0.01% 1546
2020
Q3
$1.66M Sell
27,308
-1,085
-4% -$69K ﹤0.01% 1605
2020
Q2
$1.88M Buy
28,393
+2,715
+11% +$173K ﹤0.01% 1550
2020
Q1
$1.43M Sell
25,678
-1,986
-7% -$151K ﹤0.01% 1588
2019
Q4
$2.32M Buy
27,664
+1,360
+5% +$107K ﹤0.01% 1561
2019
Q3
$1.95M Buy
26,304
+165
+0.6% +$11.1K ﹤0.01% 1583
2019
Q2
$1.64M Buy
26,139
+2,791
+12% +$155K ﹤0.01% 1659
2019
Q1
$1.09M Buy
23,348
+4,280
+22% +$227K ﹤0.01% 1802
2018
Q4
$902K Sell
19,068
-1,627
-8% -$86K ﹤0.01% 1837
2018
Q3
$1.33M Buy
20,695
+705
+4% +$44.5K ﹤0.01% 1755
2018
Q2
$1.2M Buy
19,990
+237
+1% +$15K ﹤0.01% 1765
2018
Q1
$1.41M Sell
19,753
-333
-2% -$23.8K ﹤0.01% 1662
2017
Q4
$1.37M Buy
20,086
+11,290
+128% +$807K ﹤0.01% 1677
2017
Q3
$681K Buy
8,796
+1,502
+21% +$109K ﹤0.01% 1957
2017
Q2
$494K Buy
7,294
+2
+0% +$131 ﹤0.01% 2066
2017
Q1
$443K Hold
7,292
﹤0.01% 2110
2016
Q4
$458K Sell
7,292
-8
-0.1% -$482 ﹤0.01% 2083
2016
Q3
$407K Hold
7,300
﹤0.01% 2088
2016
Q2
$315K Hold
7,300
﹤0.01% 2142
2016
Q1
$305K Buy
+7,300
New +$270K ﹤0.01% 2146
2015
Q4
Sell
-8,200
Closed -$262K 2527
2015
Q3
$262K Hold
8,200
﹤0.01% 2187
2015
Q2
$282K Hold
8,200
﹤0.01% 2226
2015
Q1
$299K Hold
8,200
﹤0.01% 2193
2014
Q4
$347K Hold
8,200
﹤0.01% 2118
2014
Q3
$322K Hold
8,200
﹤0.01% 2129
2014
Q2
$333K Hold
8,200
﹤0.01% 2130
2014
Q1
$291K Sell
8,200
-30,400
-79% -$1.15M ﹤0.01% 2167
2013
Q4
$1.6M Sell
38,600
-30,900
-44% -$1.31M ﹤0.01% 1578
2013
Q3
$2.98M Sell
69,500
-4,500
-6% -$184K ﹤0.01% 1485
2013
Q2
$3.14M Buy
+74,000
New +$3.16M ﹤0.01% 1472

Other funds holding ITRI

T. Rowe Price Associates's ITRI Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Itron (ITRI) stake by 10% in Q1 2026, selling an estimated $6.1M and leaving 544,444 shares worth $48.8M. The position accounts for 0.01% of the portfolio, ranked #775.

T. Rowe Price Associates first reported a position in ITRI in Q2 2013 and has held it in 51 quarters since. The position peaked at $91.1M in Q3 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • T. Rowe Price Associates held 544,444 shares of Itron worth $48.8M as of Q1 2026.
  • T. Rowe Price Associates sold 63,497 Itron shares in Q1 2026, an estimated $6.1M.
  • Itron made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #775 holding.
  • T. Rowe Price Associates first reported a position in Itron in Q2 2013 and has held it in 51 quarters since.
  • T. Rowe Price Associates's Itron position peaked at $91.1M in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.